Illustrates that the KIT ligand stem-cell-factor can replace erythropoietin (EPO) in supporting the growth and survival of HCD57 cells, an EPO-dependent erythroid-progenitor cell line expressing high levels of KIT. Indication that KIT may activate the EPO receptor by tyrosine phosphorylation.